Device Trial Radar · NCT04394546
CHAMPION-AF Clinical Trial
Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
3,000
Actual
Start
Oct 15, 2020
Primary completion
Dec 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Boston Scientific CorporationPublic (BSX)
- Sponsor type
- Industry
- First posted
- May 19, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to determine if left atrial appendage closure (LAAC) with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.
Conditions
- Atrial Fibrillation
- Stroke
- Bleeding
Interventions
WATCHMAN FLX LAAC DeviceDevice
WATCHMAN FLX LAAC Device Implantation
Non-Vitamin K Oral AnticoagulantDrug
Initiation or continuation of a NOAC drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- WATCHMAN FLX is non-inferior (NI) for the occurrence of stroke, cardiovascular death, and systemic embolismTime frame: 36-months
- WATCHMAN FLX is superior for non-procedural bleeding (ISTH major bleeding and clinically relevant non-major bleeding)Time frame: 36-months
- WATCHMAN FLX is non-inferior (NI) for the occurrence of ischemic stroke and systemic embolismTime frame: 60-months
Locations
141 sites in 16 countries. Site status is shown where the registry gives one.
Grandview Medical Center
Birmingham, Alabama
University of Alabama at Birmingham
Birmingham, Alabama
Arizona Arrhythmia Research Center
Phoenix, Arizona
138 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.